InvestorsHub Logo
icon url

couldbebetter

07/14/23 7:19 AM

#411992 RE: dukesking #411990

Dukesking, That is a comprehensive list of possible combinations mostly
related to CVD. If there is any significant value to be realized by any of
such "combos" it would have to done by a BP capable of selling it. Without
that these are worthless. I have doubts about combo drugs being viable
as even though they may be more practical (especially if combined into a
one a day combo product,) pharmacies would rather offer generics.

My opinion is I would rather see resources used to interest BP in uses of
Vascepa (or a future one a day version) for other indications such as Alzheimers
& Cancer. (I really would like to see a BP such as MRK which has the Cancer
drug Keytruda do a study to find out if Vascepa with "any other Cancer drug
or therapy" would lead to better outcomes for Cancer patients especially a
reduction in complications. Imagine if a BP such as MRK believed that using
Vascepa with any Cancer therapy/drug improved outcomes for patients! Now
that would be worth a massive amount to that BP.
icon url

ilovetech

07/14/23 9:53 AM

#411997 RE: dukesking #411990

Thanks Duke:)